Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Retin Cases Brief Rep ; 8(2): 107-9, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25372321

RESUMEN

PURPOSE: To report a case of presumed gemcitabine-induced retinopathy and nephropathy. METHODS: Case Report. Retrospective chart review. RESULTS: A 64-year-old woman with a recent diagnosis of metastatic cholangiocarcinoma presented with progressive visual loss and renal failure shortly after the initiation of a chemotherapy regimen which included gemcitabine. Clinical examination and fluorescein angiography showed findings of severe retinal ischemia. CONCLUSION: Although gemcitabine chemotherapy has been reported to cause a Purtscher-like retinopathy, we propose in our patient a gemcitabine-induced vasculopathy that lead to significant retinal and renal ischemia.


Asunto(s)
Antimetabolitos Antineoplásicos/efectos adversos , Desoxicitidina/análogos & derivados , Fallo Renal Crónico/inducido químicamente , Enfermedades de la Retina/inducido químicamente , Trastornos de la Visión/inducido químicamente , Desoxicitidina/efectos adversos , Femenino , Humanos , Persona de Mediana Edad , Estudios Retrospectivos , Gemcitabina
2.
Am J Ophthalmol ; 157(5): 1048-55, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24487049

RESUMEN

PURPOSE: To evaluate the effects of epiretinal membranes on the response of uveitic macular edema to therapy and on visual acuity outcomes. DESIGN: Retrospective case series. METHODS: One hundred four eyes of 77 patients with uveitic macular edema were identified at a tertiary care center. Epiretinal membranes were diagnosed when identified by 2 investigators' grading of spectral-domain optical coherence tomography and scored for the presence or absence of surface wrinkling. Outcomes included best-corrected visual acuity, central subfield thickness, and rates of macular edema improvement (>20% reduction in central subfield thickness) and resolution (reduction of central subfield thickness to <315 µm) at 3 and 6 months follow-up. RESULTS: Seventy-two eyes of 59 patients had an epiretinal membrane on presentation. Eyes without epiretinal membranes and with epiretinal membranes without surface wrinkling were not significantly different at presentation or at 3 and 6 months follow-up. Conversely, eyes with an epiretinal membrane with retinal surface wrinkling had a greater proportion of eyes with 20/200 or worse visual acuity at presentation, and had worse mean acuities at 3 months (20/94 vs 20/35 for eyes without an epiretinal membrane, P = .002) and at 6 months follow-up (20/110 vs 20/36 for eyes without an epiretinal membrane, P = .02). At 6 months of follow-up the mean central subfield thicknesses were: eyes without an epiretinal membrane, 338 ± 23 µm; and eyes with an epiretinal membrane and surface wrinkling, 405 ± 22 µm (P = .05). CONCLUSIONS: In eyes with epiretinal membranes and retinal surface wrinkling, uveitic macular edema had a poorer visual acuity response to medical therapy and thicker maculae at 6 months.


Asunto(s)
Membrana Epirretinal/fisiopatología , Edema Macular/fisiopatología , Uveítis/fisiopatología , Trastornos de la Visión/fisiopatología , Agudeza Visual/fisiología , Administración Oral , Adulto , Anciano , Membrana Epirretinal/diagnóstico , Femenino , Glucocorticoides/uso terapéutico , Humanos , Inmunosupresores/uso terapéutico , Inyecciones Intravítreas , Edema Macular/diagnóstico , Edema Macular/tratamiento farmacológico , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Tomografía de Coherencia Óptica , Uveítis/diagnóstico , Uveítis/tratamiento farmacológico , Trastornos de la Visión/diagnóstico , Trastornos de la Visión/tratamiento farmacológico
3.
Retina ; 29(8): 1188-92, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19491724

RESUMEN

PURPOSE: To determine if Preferential Hyperacuity Perimetry (PHP) testing can detect the presence of retinal toxicity due to hydroxychloroquine (HCQ) or chloroquine administration. METHODS: Fifteen patients were divided into three groups. Five patients had confirmed HCQ or chloroquine toxicity, five patients had suspected HCQ toxicity, and five patients had history of long-term use of HCQ or chloroquine but no evidence of toxicity. All patients underwent PHP testing. RESULTS: All patients with either known or suspected toxicity based upon standardized visual field testing and/or fluorescein angiography demonstrated significant hyperacuity defects on PHP testing. None of the patients on long-term HCQ therapy, without clinical suspicion of toxicity, demonstrated a PHP hyperacuity defect. CONCLUSION: Results of this pilot study with patients with known or suspected HCQ or chloroquine toxicity suggest that PHP may be a useful adjunct for testing of patients suspicious for toxicity due to these medications. Further testing is warranted.


Asunto(s)
Antirreumáticos/efectos adversos , Hidroxicloroquina/efectos adversos , Enfermedades de la Retina/diagnóstico , Pruebas del Campo Visual/métodos , Adulto , Anciano , Anciano de 80 o más Años , Artritis/tratamiento farmacológico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proyectos Piloto , Retina/efectos de los fármacos , Enfermedades de la Retina/inducido químicamente
4.
Graefes Arch Clin Exp Ophthalmol ; 247(4): 469-75, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19034480

RESUMEN

BACKGROUND: Paintball-related ocular injuries result in severe damage and loss of vision. Despite efforts to increase public awareness and improve safety features, the incidence of eye injuries has increased over time. We examined the characteristics and ocular effects of paintball injury at our tertiary referral center. METHODS: Retrospective review of charts of patients with paintball injury between 1998-2005. RESULTS: Fourteen patients were evaluated for paintball injury; 13 (93%) were male and one (7%) was female. Average age was 17 years (range from 9 to 30). Thirteen patients (95%) did not wear eye protection; one is unknown. Injuries occurred while playing paintball in three patients (21%); ten (71%) were injured in either accidental (four patients) or intentional (six patients) shootings not associated with play. Minimum follow-up was 6 weeks, except for one patient who was lost to follow-up. Seven patients (50%) had final visual acuity (VA) better than 20/200, six patients (43%) were 20/200 or worse, and information on one patient was not available. VA, except in one case, improved with treatment. Decreased VA in this case was due to proliferative vitreoretinopathy (PVR). Hyphema was noted in ten patients (71%), vitreous hemorrhage in eight (57%), retinal hemorrhage in six (43%), retinal tear or detachment in six (43%), commotio retinae in six (43%), iris injury in five (36%), keratopathy in four (29%), lens injury in two (14%), subluxation of lens in two (14%), secondary glaucoma in two (14%), open globe/intraocular foreign body (IOFB) in one (7%), choroidal rupture in one (7%), and proliferative vitreoretinopathy (PVR) in one (7%). Ten patients (71%) required intervention (surgery, laser retinopexy or cryotherapy). CONCLUSION: Paintball trauma results in significant ocular injury and loss of vision. Most injuries occur in unsupervised settings without proper eye protection. Ten patients (71%) were injured in accidental or intentional shootings. Lack of supervision and use of paintball materials as assault weapons make the risk for ocular injury more significant. Improved safety features of paintball equipment, along with continued education of proper eye protection, may reduce the incidence of severe ocular injuries.


Asunto(s)
Traumatismos en Atletas/etiología , Lesiones Oculares/etiología , Juego e Implementos de Juego/lesiones , Heridas no Penetrantes/etiología , Adolescente , Adulto , Traumatismos en Atletas/cirugía , Niño , Lesiones Oculares/cirugía , Dispositivos de Protección de los Ojos , Femenino , Estudios de Seguimiento , Humanos , Hipema/etiología , Hipema/cirugía , Masculino , Pintura , Enfermedades de la Retina/etiología , Enfermedades de la Retina/cirugía , Estudios Retrospectivos , Agudeza Visual
5.
Ocul Immunol Inflamm ; 16(3): 123-6, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18569804

RESUMEN

PURPOSE: To describe the clinical course of a case of intravascular lymphoma. DESIGN: Case report. METHODS: Retrospective chart review. RESULTS: A 56-year-old man presented with blurry vision associated with fever and decreased hearing. Ocular exam including fluorescein angiography and OCT was consistent with Vogt-Koyanagi-Harada syndrome and the patient initially improved with corticosteroids. Clinical deterioration led to further systemic workup and revealed intravascular lymphoma. The patient was started on chemotherapy with resolution of visual complaints. CONCLUSIONS: Intravascular lymphoma can present as a masquerade of VKH syndrome. Diagnosis can be aided with measurement of LDH and skin biopsy.


Asunto(s)
Linfoma/diagnóstico , Síndrome Uveomeningoencefálico/diagnóstico , Neoplasias Vasculares/diagnóstico , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Biopsia , Vasos Sanguíneos/patología , Ciclofosfamida/uso terapéutico , Diagnóstico Diferencial , Doxorrubicina/uso terapéutico , Angiografía con Fluoresceína , Humanos , L-Lactato Deshidrogenasa/sangre , Linfoma/complicaciones , Linfoma/tratamiento farmacológico , Linfoma/enzimología , Masculino , Persona de Mediana Edad , Prednisolona/uso terapéutico , Rituximab , Piel/patología , Resultado del Tratamiento , Neoplasias Vasculares/complicaciones , Neoplasias Vasculares/tratamiento farmacológico , Neoplasias Vasculares/enzimología , Vincristina/uso terapéutico , Trastornos de la Visión/etiología
6.
Arch Ophthalmol ; 121(7): 997-1001, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12860804

RESUMEN

BACKGROUND: Sun glare decreases athletes' contrast sensitivity and impairs their ability to distinguish objects from background. Many commercial products claim to reduce glare but have not been proven effective in clinical studies. OBJECTIVE: To determine whether glare-reducing products such as eye black grease and antiglare stickers reduce glare and improve contrast sensitivity during sunlight exposure. DESIGN AND METHODS: We tested 46 subjects for contrast sensitivity using a Pelli-Robson contrast chart. Each subject served as an internal control and then was randomized to either application of eye black grease, antiglare stickers, or petroleum jelly at the infraorbital rim. All testing was performed in conditions of unobstructed sunlight. RESULTS: Analysis of variance revealed a significant difference between eye black grease (mean +/- SD, Pelli-Robson value, 1.87 +/- 0.09 logMAR units) and antiglare stickers (1.75 +/- 0.14 logMAR units) in binocular testing (P =.02). No statistical difference was found between the groups in right eyes, left eyes, or in combined data from the right and left eyes. Paired t tests demonstrated a significant difference between control (mean +/- SD, 1.77 +/- 0.14 logMAR units) and eye black grease (1.87 +/- 0.09 logMAR units) in binocular testing (P =.04). There was also a significant difference between control (mean +/- SD, 1.65 +/- 0.05 logMAR units) and eye black grease (1.67 +/- 0.06 logMAR units) in combined data from the right and left eyes (P =.02). CONCLUSION: Eye black grease reduces glare and improves contrast sensitivity in conditions of sunlight exposure compared with the control and antiglare stickers in binocular testing.


Asunto(s)
Sensibilidad de Contraste/fisiología , Dispositivos de Protección de los Ojos/estadística & datos numéricos , Deslumbramiento , Luz Solar , Trastornos de la Visión/fisiopatología , Adolescente , Adulto , Exposición a Riesgos Ambientales , Femenino , Humanos , Masculino , Órbita , Luz Solar/efectos adversos , Trastornos de la Visión/etiología , Trastornos de la Visión/prevención & control , Visión Binocular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA